DE602005015981D1 - Chimäre zwischen einer alpha-Kette eines humanen IgE Rezeptor und konstanten Immunoglobulin-Domänen von Vögeln zur Determination von Serum IgE. - Google Patents

Chimäre zwischen einer alpha-Kette eines humanen IgE Rezeptor und konstanten Immunoglobulin-Domänen von Vögeln zur Determination von Serum IgE.

Info

Publication number
DE602005015981D1
DE602005015981D1 DE602005015981T DE602005015981T DE602005015981D1 DE 602005015981 D1 DE602005015981 D1 DE 602005015981D1 DE 602005015981 T DE602005015981 T DE 602005015981T DE 602005015981 T DE602005015981 T DE 602005015981T DE 602005015981 D1 DE602005015981 D1 DE 602005015981D1
Authority
DE
Germany
Prior art keywords
chimera
birds
determination
alpha chain
immunoglobulin domains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602005015981T
Other languages
English (en)
Inventor
Ingke Braren
Reinhard Prof Bredehorst
Thomas Dr Grunwald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PLS-Design GmbH
Original Assignee
PLS-Design GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PLS-Design GmbH filed Critical PLS-Design GmbH
Publication of DE602005015981D1 publication Critical patent/DE602005015981D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70535—Fc-receptors, e.g. CD16, CD32, CD64 (CD2314/705F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE602005015981T 2005-10-17 2005-10-17 Chimäre zwischen einer alpha-Kette eines humanen IgE Rezeptor und konstanten Immunoglobulin-Domänen von Vögeln zur Determination von Serum IgE. Active DE602005015981D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05022582A EP1777524B1 (de) 2005-10-17 2005-10-17 Chimäre zwischen einer alpha-Kette eines humanen IgE Rezeptor und konstanten Immunoglobulin-Domänen von Vögeln zur Determination von Serum IgE.

Publications (1)

Publication Number Publication Date
DE602005015981D1 true DE602005015981D1 (de) 2009-09-24

Family

ID=35311875

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005015981T Active DE602005015981D1 (de) 2005-10-17 2005-10-17 Chimäre zwischen einer alpha-Kette eines humanen IgE Rezeptor und konstanten Immunoglobulin-Domänen von Vögeln zur Determination von Serum IgE.

Country Status (5)

Country Link
US (1) US7897153B1 (de)
EP (1) EP1777524B1 (de)
AT (1) ATE439598T1 (de)
DE (1) DE602005015981D1 (de)
DK (1) DK1777524T3 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2309263B1 (de) * 2009-09-14 2015-06-17 PLS-Design GmbH Chimerische IgYFc-Rezeptorkonstrukte
HUE033492T2 (en) * 2009-10-26 2017-12-28 Genentech Inc Tests for the detection of antibodies specific for therapeutic anti-verb antibodies and their use in anaphylaxis
US20110256641A1 (en) * 2010-04-19 2011-10-20 Michael Ling Methods and Systems for Detecting Free IgE
JP7127859B2 (ja) 2016-11-09 2022-08-30 ノース カロライナ ステート ユニバーシティ キメラタンパク質を用いたアレルギー疾患の治療
CN110577598B (zh) * 2018-06-11 2022-03-08 李莉 抗sFcεRIα单克隆抗体及其应用
CN110305207B (zh) * 2019-06-14 2021-06-15 广州康盛生物科技股份有限公司 一种可溶性人IgE受体蛋白截短蛋白及其制备方法与应用
CN110672844A (zh) * 2019-10-29 2020-01-10 华中科技大学 一种新城疫病毒抗体磁免疫化学发光检测试剂盒及其应用
EP4306956A1 (de) * 2022-07-15 2024-01-17 Justus-Liebig-Universität Gießen Verfahren zum in-vitro nachweis antigen-spezifischer ige verursacht durch eine infektion mit parasiten oder pilzen

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945294A (en) * 1996-11-26 1999-08-31 Heska Corporation Method to detect IgE
US6737056B1 (en) * 1999-01-15 2004-05-18 Genentech, Inc. Polypeptide variants with altered effector function
US6608172B1 (en) * 2000-06-09 2003-08-19 Good Biotech Corporation Isolation of IgY (ΔFc) antibodies
WO2003091285A1 (en) 2002-04-26 2003-11-06 Genpat77 Pharmacogenetics Ag Bispecific molecules for use in therapy and diagnosis of immune related and other diseases

Also Published As

Publication number Publication date
ATE439598T1 (de) 2009-08-15
EP1777524B1 (de) 2009-08-12
DK1777524T3 (da) 2009-12-14
US7897153B1 (en) 2011-03-01
EP1777524A1 (de) 2007-04-25

Similar Documents

Publication Publication Date Title
DE602005015981D1 (de) Chimäre zwischen einer alpha-Kette eines humanen IgE Rezeptor und konstanten Immunoglobulin-Domänen von Vögeln zur Determination von Serum IgE.
MA32449B1 (fr) Agents de liaison de notch et antagonistes de notch ainsi que procedes d'utilisation correspondants
ES2633597T3 (es) Anticuerpos con afinidad modificada para FcRn que promueven la eliminación del antígeno
AR062709A1 (es) Antagonistas del gen wnt y su uso en el diagnostico y tratamiento de trastornos mediados por el wnt
CY1126121T1 (el) Πρωτεϊνες συντηξης υποδοχεα tgf-bhta τυπου ii και χρησεις aυτων
ATE452913T1 (de) Bivalente igy antikörperkonstrukte für diagnostische und therapeutische anwendungen
PA8782201A1 (es) Anticuerpo humanizados contra el globulómero ab(20-42) y sus usos
ATE556717T1 (de) Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus
EA201592049A1 (ru) Антитело с "запирающими" свойствами для инактивации лекарства белкового происхождения
BRPI0517967B8 (pt) anticorpo isolado que liga-se a tenascina-c humana
WO2018218056A8 (en) ANTIBODIES COMPRISING MODIFIED HEAVY CHAIN CONSTANT CHAIN REGIONS
ATE517922T1 (de) Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
RU2599417C3 (ru) Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
CU20120095A7 (es) Antagonistas de pcsk9
ATE359090T1 (de) Monoklonale antikörper spezifisch gegen vegf- rezeptoren und ihre verwendung
ATE525033T1 (de) Optische sonde zur abgabe von licht
MX2012012927A (es) Composiciones y metodos de uso para anticuerpos multivalentes terapeuticos de proteina relacionada con lipoproteina de baja densidad 6 (lrp6).
DOP2007000089A (es) Proteínas de fusión rag, formulaciones y métodos de empleos de las mismas
CL2007003236A1 (es) Anticuerpos agonistas del receptor tirosina quinasa b (trkb); composicion farmaceutica que lo comprende; y su uso para reducir los niveles de glucosa en la sangre y/o peso corporal en un individuo que lo necesite.
DE602008006041D1 (de) CHIMÄRER Fc GAMMA REZEPTOR UND VERFAHREN ZUR BESTIMMUNG VON ADCC-AKTIVITÄT UNTER VERWENDUNG DES REZEPTORS
EA016245B9 (ru) Антитела против альфа2-интегрина и их применение
ATE510561T1 (de) Kdr-spezifische menschliche antikörper und ihre verwendung
DE602004012564D1 (de) Chinolin- und chinazolinderivate mit affinität für rezeptoren vom 5ht1-typ
CL2007002668A1 (es) Proteina de union a antigeno que se une al receptor de glucagon humano; acido nucleico que la codifica; metodo de produccion; composicion farmaceutica que la comprende; y su uso para tratar o prevenir la diabetes tipo 2.
SG10201510111PA (en) Human monoclonal antibody with specificity for dengue virus serotype 1 e protein and uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1777524

Country of ref document: EP

Representative=s name: ,